Nuvectis Pharma (NVCT) Shares Outstanding (2021 - 2026)

Nuvectis Pharma has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $26.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 12.23% year-over-year to $26.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.5 million (up 12.23% YoY) and the FY2025 annual result came in at $25.7 million, up 31.71% from the prior year.
• Shares Outstanding (Entity) climbed to $26.5 million in Q1 2026 per NVCT's latest filing, from $25.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $26.5 million in Q1 2026 and troughed at $9.2 million in Q1 2022.
• A 5-year average of $18.7 million and a median of $18.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) surged 224.99% in 2022, then gained 8.87% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $12.7 million in 2022, then jumped by 37.62% to $17.4 million in 2023, then climbed by 11.92% to $19.5 million in 2024, then jumped by 31.71% to $25.7 million in 2025, then increased by 3.31% to $26.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $26.5 million, $25.7 million, and $25.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.